 |
 |
|
|
|
|
|
|
About Us > Management Bios
Martin Schmieg has over 20 years of experience launching and building businesses in the medical device, biotechnology and life sciences industries. As CEO of Nuvilex, Inc., he drives all aspects of company development.
Prior to Nuvilex, Martin repeatedly transitioned companies with innovative technologies to successful product based enterprises, while increasing valuation through his proven financial management, negotiation skills and aggressive fundraising capabilities. Working with companies such as Sirna Therapeutics, Advanced Bionics and Cytometrics, he raised capital in excess of $55 million for one enterprise, raised the market capitalization of another from $0 to $200 million, and was the financial architect of a $4.2 billion sale of a third company to a Fortune 500 company.
Martin's executive experience spans operating functions including finance and management to marketing and business strategy. He holds a BS in Business Administration from LaSalle University and is a Guest Lecturer at the MIT Sloan School of Management and at the University of Pennsylvania's School of Engineering, Arts and Sciences. He is a Mentor at the Port of Technology, University City Science Center's business development incubator. He is a CPA in Pennsylvania.
Blair Barnes brings over 25 years of experience in finance, business analysis and capital fund raising to Nuvilex. She is responsible for all financial operations and investor relations activities for the company including business development; technology licensing and investor development.
With an extensive background in investment banking and hedge fund management, she has repeatedly improved the performance and added investors to funds for firms such as Craig Drill Capital, Bedford Oak Advisors and Henderson Brothers, Inc. Most recently as the VP of Business Development for Nuvilex, Blair was instrumental in raising three rounds of financing to launch the company. She is the treasurer and secretary for the company.
Blair began her career in finance as an assistant trader at Lehman Brothers. She holds a BA from Sweet Briar College in Political Economics and Business.
|
A. Peter Morello III, Ph.D.
Vice President of Research and Development
pmorello@nuvilex.com
Peter Morello is an accomplished research scientist and sought-after speaker in the fields of molecular pharmacology, physiology, and biotechnology. As a member of Brown University's Division of Biology and Medicine, Department of Molecular Pharmacology, Physiology, and Biotechnology, his most recent research focused on the evaluation of pigments engineered for removal and quantitative biodistribution of microsphere drug delivery systems. He is a co-holder of the (WIPO) patent Drug Delivery Formulations for Targeted Delivery (November 23, 2006).' His research is fundamental to Nuvilex's product development.
A regular contributor to peer-reviewed journals and symposiums, Peter has co-authored articles for Lasers in Surgery and Medicine and the Journal of Microencapsulation on "In vivo evaluation of pigments engineered for removal"; "Preparation and characterization of poly (methyl methacrylate) iron (III) oxide microparticles using a modified solvent evaporation method"; and "Investigating the effects of surfactants on the size and hydrolytic stability of poly (adipic anhydride) particles". These topics are directly applicable to the formulations of Nuvilex's permanent, but more easily removable, tattoo ink Infinitink.
Peter's research work extends beyond the lab environment. He is an instructor at Brown University and his clinical experience in hospital settings includes interaction with patients to assess medical conditions. He is also involved in the development of database systems that enabled a high rate (>99.5%) of patient post-operative follow-up.
Educated at Brown University, Peter has a Ph.D., Medical Science and Bachelor of Science in Biophysics.
' WORLD INTELLECTUAL PROPERTY ORGANIZATION (WIPO) PATENTS
WIPO WO 2006/125074. Morello, A.P., Reineke, J., Cheifetz, P.M., Laulicht, B., Mathiowitz, E. Drug Delivery Formulations for Targeted Delivery. November 23, 2006.
|
Steven Kushner, Ph.D.
Nutritional Consultant
skushner@nuvilex.com
Dr. Kushner brings more than twenty-three years of experience in the field of nutrition to eFoodSafety.com, where his focus is on product evaluation and development. He has studied, and utilizes the concepts of Dr. Hazel Parcells, one of the foremost nutritionists of the 20th century. Dr. Kushner is primarily engaged in the research and development of unique food and nutritional products that contain properties associated with healing, including herbs, enzymes, homeopathy, phytonutrients, and trace minerals. He first introduced homeopathic amino acids into the mass market for sports nutrition. Dr. Kushner was awarded his Ph.D. for his dissertation on the subject of protomorphogens and their assimilation into the body for improving various areas of health.
|
|
|
|
|
|
|
|
|
|
© Copyright 2009 Nuvilex
|
|
|
|
|
